SynbiCITE welcomes RebelBio to London
- Posted on 6 December, 2017
We're the world's first early stage life sciences accelerator. Twice a year we invest up to $250K in startups solving global challenges with life itself. We run a crucible that transforms scientists into entrepreneurs.
On top of our cash investment, during the program, teams have access to a fully equipped biosafety level lab, co-working space, dedicated mentorship and the support of a network of RebelBio alumni, investors, corporates and press partners.
RebelBio is an SOSV Accelerator.
Apply here: https://goo.gl/iencnF
Share this article:
People also read
Evonetix makes key appointments to support development of novel gene synthesis technology
CAMBRIDGE, UK, 18 September 2018 – EVONETIX LTD (‘Evonetix’), the company pioneering an innovative approach to scalable and high-fidelity gene synthes...
Buildings made from fungi? Meet London’s pop-up bio-lab innovators
If there’s one place you wouldn’t expect a new biotech research lab to be built, it’s slap bang in the middle of a busy London marketFind out more her...
A Lloyd's Emerging Risk Report
Synthetic biology, the application of engineering principles to genetic modification is a market forecast to grow to $39bn by 2020. In recent years sc...